Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Neoplasms 2Motor Activity 1Colonic Neoplasms 1

Interventions

Specimen Handling 629pembrolizumab 559Magnetic Resonance Spectroscopy 539Carboplatin 423Cyclophosphamide 371Cisplatin 371Biopsy 357Paclitaxel 304Nivolumab 301Gemcitabine 299Radiotherapy 270Bevacizumab 238Dexamethasone 207fludarabine 205Docetaxel 189durvalumab 178atezolizumab 176Oxaliplatin 172Fluorouracil 167venetoclax 164Rituximab 164Pemetrexed 162Radiation 159Doxorubicin 159Capecitabine 158Radiosurgery 147Etoposide 137Ipilimumab 134Leucovorin 133Lenalidomide 130

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Health Surveys × 90 days × Clear all
NCT06773897 2026-05-22

RUGCC-BC

Rutgers, The State University of New Jersey

Recruiting
25,000 enrolled
Breast

Breast Neoplasms

NCT06340503 2026-03-19

Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors

Wake Forest University Health Sciences

Phase NA Active not recruiting
20 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡